117 related articles for article (PubMed ID: 37778157)
1. Patients with multiple sclerosis: COVID-19 related disease activity and hospitalisations based on a nationwide cohort study.
Andersen ML; Zegers FD; Jølving LR; Knudsen T; Stenager E; Nørgård BM
Mult Scler Relat Disord; 2023 Nov; 79():105031. PubMed ID: 37778157
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 Does Not Lead to an Increase in Corticosteroid Prescriptions in IBD Patients: A Nationwide Cohort Study.
Nørgård BM; Zegers FD; Nielsen J; Knudsen T; Kjeldsen J
Inflamm Bowel Dis; 2023 Sep; 29(9):1470-1476. PubMed ID: 37067508
[TBL] [Abstract][Full Text] [Related]
3. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.
Bager P; Wohlfahrt J; Fonager J; Rasmussen M; Albertsen M; Michaelsen TY; Møller CH; Ethelberg S; Legarth R; Button MSF; Gubbels S; Voldstedlund M; Mølbak K; Skov RL; Fomsgaard A; Krause TG;
Lancet Infect Dis; 2021 Nov; 21(11):1507-1517. PubMed ID: 34171231
[TBL] [Abstract][Full Text] [Related]
4. Clinical, demographical characteristics and hospitalisation of 3,010 patients with Covid-19 in Friuli Venezia Giulia Region (Northern Italy). A multivariate, population-based, statistical analysis.
Gobbato M; Clagnan E; Burba I; Rizzi L; Grassetti L; Del Zotto S; Dal Maso L; Serraino D; Tonutti G
Epidemiol Prev; 2020; 44(5-6 Suppl 2):226-234. PubMed ID: 33412814
[TBL] [Abstract][Full Text] [Related]
5. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
[TBL] [Abstract][Full Text] [Related]
6. Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry.
Spelman T; Forsberg L; McKay K; Glaser A; Hillert J
Mult Scler; 2022 Jun; 28(7):1051-1059. PubMed ID: 34212816
[TBL] [Abstract][Full Text] [Related]
7. Safety and effectiveness of monovalent COVID-19 mRNA vaccination and risk factors for hospitalisation caused by the omicron variant in 0.8 million adolescents: A nationwide cohort study in Sweden.
Nordström P; Ballin M; Nordström A
PLoS Med; 2023 Feb; 20(2):e1004127. PubMed ID: 36802397
[TBL] [Abstract][Full Text] [Related]
8. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.
Nordström P; Ballin M; Nordström A
Lancet Infect Dis; 2022 Jun; 22(6):781-790. PubMed ID: 35366962
[TBL] [Abstract][Full Text] [Related]
9. Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark.
Hansen CH; Friis NU; Bager P; Stegger M; Fonager J; Fomsgaard A; Gram MA; Christiansen LE; Ethelberg S; Legarth R; Krause TG; Ullum H; Valentiner-Branth P
Lancet Infect Dis; 2023 Feb; 23(2):167-176. PubMed ID: 36270311
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis.
Smith JB; Gonzales EG; Li BH; Langer-Gould A
JAMA Netw Open; 2022 Dec; 5(12):e2248664. PubMed ID: 36576740
[TBL] [Abstract][Full Text] [Related]
11. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
Hasseli R; Mueller-Ladner U; Hoyer BF; Krause A; Lorenz HM; Pfeil A; Richter J; Schäfer M; Schmeiser T; Strangfeld A; Schulze-Koops H; Voll RE; Specker C; Regierer AC
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33479021
[TBL] [Abstract][Full Text] [Related]
12. Mortality and life-years lost following subsequent physical comorbidity in people with pre-existing substance use disorders: a national registry-based retrospective cohort study of hospitalised individuals in Czechia.
Formánek T; Krupchanka D; Mladá K; Winkler P; Jones PB
Lancet Psychiatry; 2022 Dec; 9(12):957-968. PubMed ID: 36335974
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 clinical outcomes and DMT of MS patients and population-based controls.
Longinetti E; Bower H; McKay KA; Englund S; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Nilsson P; Salzer J; Svenningsson A; Mellergård J; Olsson T; Piehl F; Frisell T
Ann Clin Transl Neurol; 2022 Sep; 9(9):1449-1458. PubMed ID: 35993445
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis and cancer incidence: A Danish nationwide cohort study.
Nørgaard M; Veres K; Didden EM; Wormser D; Magyari M
Mult Scler Relat Disord; 2019 Feb; 28():81-85. PubMed ID: 30576846
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark.
Nielsen NM; Frisch M; Rostgaard K; Wohlfahrt J; Hjalgrim H; Koch-Henriksen N; Melbye M; Westergaard T
Mult Scler; 2008 Jul; 14(6):823-9. PubMed ID: 18573841
[TBL] [Abstract][Full Text] [Related]
16. Association between disease-modifying therapies for multiple sclerosis and healthcare utilisation on a population level: a retrospective cohort study.
Al-Sakran L; Marrie RA; Blackburn D; Knox K; Evans C
BMJ Open; 2019 Nov; 9(11):e033599. PubMed ID: 31772108
[TBL] [Abstract][Full Text] [Related]
17. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study.
Bager P; Wohlfahrt J; Bhatt S; Stegger M; Legarth R; Møller CH; Skov RL; Valentiner-Branth P; Voldstedlund M; Fischer TK; Simonsen L; Kirkby NS; Thomsen MK; Spiess K; Marving E; Larsen NB; Lillebaek T; Ullum H; Mølbak K; Krause TG;
Lancet Infect Dis; 2022 Jul; 22(7):967-976. PubMed ID: 35468331
[TBL] [Abstract][Full Text] [Related]
18. Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.
Bhaskaran K; Rentsch CT; Hickman G; Hulme WJ; Schultze A; Curtis HJ; Wing K; Warren-Gash C; Tomlinson L; Bates CJ; Mathur R; MacKenna B; Mahalingasivam V; Wong A; Walker AJ; Morton CE; Grint D; Mehrkar A; Eggo RM; Inglesby P; Douglas IJ; McDonald HI; Cockburn J; Williamson EJ; Evans D; Parry J; Hester F; Harper S; Evans SJ; Bacon S; Smeeth L; Goldacre B
PLoS Med; 2022 Jan; 19(1):e1003871. PubMed ID: 35077449
[TBL] [Abstract][Full Text] [Related]
19. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
20. Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022.
Martínez-Baz I; Trobajo-Sanmartín C; Miqueleiz A; Casado I; Navascués A; Burgui C; Ezpeleta C; Castilla J; Guevara M; ;
Euro Surveill; 2023 Feb; 28(5):. PubMed ID: 36729113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
